Cathie Wood’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.33M | Buy |
68,653
+374
| +0.5% | +$12.5K | 0.02% | 142 |
|
|
2026
Q1 | $2.06M | Sell |
68,279
-36,852
| -35% | -$1.19M | 0.02% | 136 |
|
|
2025
Q4 | $3.28M | Sell |
105,131
-13,590
| -11% | -$335K | 0.02% | 126 |
|
|
2025
Q3 | $2.4M | Sell |
118,721
-2,153
| -2% | -$37.8K | 0.01% | 145 |
|
|
2025
Q2 | $2.03M | Buy |
120,874
+30,621
| +34% | +$494K | 0.01% | 138 |
|
|
2025
Q1 | $1.39M | Sell |
90,253
-10,190
| -10% | -$182K | 0.01% | 156 |
|
|
2024
Q4 | $2.21M | Sell |
100,443
-23,422
| -19% | -$426K | 0.02% | 128 |
|
|
2024
Q3 | $2.23M | Sell |
123,865
-45,555
| -27% | -$797K | 0.02% | 132 |
|
|
2024
Q2 | $2.75M | Sell |
169,420
-22,716
| -12% | -$350K | 0.02% | 131 |
|
|
2024
Q1 | $2.71M | Sell |
192,136
-30,670
| -14% | -$387K | 0.02% | 149 |
|
|
2023
Q4 | $2.33M | Sell |
222,806
-32,004
| -13% | -$299K | 0.01% | 159 |
|
|
2023
Q3 | $2.6M | Buy |
254,810
+16,887
| +7% | +$157K | 0.02% | 143 |
|
|
2023
Q2 | $1.79M | Buy |
237,923
+26,145
| +12% | +$212K | 0.01% | 185 |
|
|
2023
Q1 | $1.87M | Sell |
211,778
-47,385
| -18% | -$469K | 0.01% | 176 |
|
|
2022
Q4 | $2.36M | Sell |
259,163
-76,305
| -23% | -$666K | 0.02% | 158 |
|
|
2022
Q3 | $2.71M | Buy |
335,468
+102,950
| +44% | +$910K | 0.02% | 150 |
|
|
2022
Q2 | $2.12M | Sell |
232,518
-67,494
| -22% | -$588K | 0.01% | 185 |
|
|
2022
Q1 | $2.82M | Sell |
300,012
-4,780
| -2% | -$39.9K | 0.01% | 184 |
|
|
2021
Q4 | $2.44M | Sell |
304,792
-99,204
| -25% | -$895K | 0.01% | 232 |
|
|
2021
Q3 | $3.94M | Sell |
403,996
-108,446
| -21% | -$1.02M | 0.01% | 200 |
|
|
2021
Q2 | $5.07M | Buy |
512,442
+12,598
| +3% | +$133K | 0.01% | 234 |
|
|
2021
Q1 | $5.77M | Buy |
499,844
+320,042
| +178% | +$3.67M | 0.01% | 204 |
|
|
2020
Q4 | $1.74M | Buy |
179,802
+104,715
| +139% | +$1M | ﹤0.01% | 187 |
|
|
2020
Q3 | $677K | Sell |
75,087
-24,905
| -25% | -$263K | ﹤0.01% | 179 |
|
|
2020
Q2 | $1.23M | Buy |
99,992
+43,869
| +78% | +$496K | 0.01% | 140 |
|
|
2020
Q1 | $504K | Buy |
56,123
+9,994
| +22% | +$102K | 0.01% | 128 |
|
|
2019
Q4 | $452K | Sell |
46,129
-10,569
| -19% | -$94.4K | 0.01% | 136 |
|
|
2019
Q3 | $390K | Buy |
56,698
+22,291
| +65% | +$171K | 0.01% | 168 |
|
|
2019
Q2 | $318K | Buy |
34,407
+9,945
| +41% | +$120K | 0.01% | 175 |
|
|
2019
Q1 | $384K | Buy |
24,462
+856
| +4% | +$15.1K | 0.01% | 156 |
|
|
2018
Q4 | $364K | Buy |
23,606
+543
| +2% | +$11.1K | 0.01% | 136 |
|
|
2018
Q3 | $497K | Sell |
23,063
-7,424
| -24% | -$172K | 0.02% | 146 |
|
|
2018
Q2 | $741K | Buy |
30,487
+2,561
| +9% | +$52.2K | 0.03% | 105 |
|
|
2018
Q1 | $477K | Buy |
27,926
+10,762
| +63% | +$210K | 0.02% | 142 |
|
|
2017
Q4 | $325K | Buy |
+17,164
| New | +$258K | 0.03% | 119 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Cathie Wood's TEVA Position: Q2 2026 in Review
Cathie Wood increased its Teva Pharmaceuticals (TEVA) stake by 0.55% in Q2 2026, buying an estimated $12.5K and bringing the position to 68,653 shares worth $2.33M. The position accounts for 0.02% of the portfolio, ranked #142.
Cathie Wood first reported a position in TEVA in Q4 2017 and has held it in 35 quarters since. The position peaked at $5.77M in Q1 2021. 671 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Cathie Wood held 68,653 shares of Teva Pharmaceuticals worth $2.33M as of Q2 2026.
- Cathie Wood bought 374 Teva Pharmaceuticals shares in Q2 2026, an estimated $12.5K.
- Teva Pharmaceuticals made up 0.02% of Cathie Wood's portfolio in Q2 2026, its #142 holding.
- Cathie Wood first reported a position in Teva Pharmaceuticals in Q4 2017 and has held it in 35 quarters since.
- Cathie Wood's Teva Pharmaceuticals position peaked at $5.77M in Q1 2021.
- 671 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.
Based on ARK Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.